Analyst Reco. Moderna, Inc.

Equities

MRNA

US60770K1079

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 02:30:00 07/03/2026 am IST			5-day change	1st Jan Change
52.52 ^USD	-2.43%		-1.96%	+78.09%

05/03	Berenberg Raises Price Target on Moderna to $45 From $32, Keeps Hold Rating	MT
05/03	US stocks close up on Iran diplomacy hopes; tech leads rebound	RE

Analyst Reco.

05/03	Berenberg Raises Price Target on Moderna to $45 From $32, Keeps Hold Rating	MT
27/02	Rothschild & Co Redburn Adjusts Price Target on Moderna to $40 From $36, Maintains Neutral Rating	MT
26/02	Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna…
17/02	Bernstein Adjusts Price Target on Moderna to $45 From $35, Maintains Market Perform Rating	MT
17/02	RBC Capital Adjusts Price Target on Moderna to $30 From $25, Maintains Sector Perform Rating	MT
17/02	Analyst recommendations: Accenture, Dollar Tree, DraftKings, Moderna, Walmart…
16/02	Berenberg Reiterates Sanofi at Buy on 'Significant' Share Discount	MT
13/02	RBC Raises Price Target on Moderna to $30 From $25, Keeps Sector Perform Rating	MT
13/02	Jefferies Raises Price Target on Moderna to $37 From $30	MT
11/02	Leerink Partners Adjusts Moderna PT to $12 From $17, Maintains Underperform Rating	MT
30/01	Leerink Partners Adjusts Moderna Price Target to $17 From $18, Maintains Underperform Rating	MT
29/01	TD Cowen Adjusts Moderna Price Target to $40 From $25, Maintains Hold Rating	MT
28/01	Wolfe Adjusts Price Target on Moderna to $25 From $17, Maintains Underperform Rating	MT
23/01	Bernstein Adjusts Price Target on Moderna to $35 From $25, Maintains Market Perform Rating	MT
23/01	Analyst recommendations: Amgen, P&G, Spotify, Duolingo, Moderna…
12/01	Goldman Sachs Adjusts Price Target on Moderna to $36 From $33, Maintains Neutral Rating	MT
07/01	UBS Downgrades Moderna to Neutral From Buy, Cuts Price Target to $34 From $40	MT
06/01	BofA Adjusts Price Target on Moderna to $24 From $21, Maintains Underperform Rating	MT
12/12	Morgan Stanley Adjusts Moderna Price Target to $28 From $30, Maintains Equalweight Rating	MT
12/12	Jefferies Initiates Coverage on Moderna With Hold Rating, $30 Price Target	MT
26/11	Berenberg Trims Price Target on Moderna to $26 From $28, Keeps Hold Rating	MT
21/11	Piper Sandler Adjusts Price Target on Moderna to $63 From $69, Maintains Overweight Rating	MT
21/11	Leerink Partners Adjusts Price Target on Moderna to $18 From $15, Maintains Underperform Rating	MT
21/11	RBC Cuts Price Target on Moderna to $25 From $28, Keeps Sector Perform Rating	MT
21/11	Wolfe Research Adjusts Price Target on Moderna to $17 From $16, Maintains Underperform Rating	MT